South Western Times
Vital cash injection
The Federal Government hopes to progress Australia’s slow-moving COVID-19 vaccination rollout with a further $1.9 billion of spending injected by the 2021/22 Federal Budget.
More vials of vaccines will be purchased — including 30 million more Pfizer/Biotech mRNA doses — to bring Australia’s total order of Pfizer, AstraZeneca and Novavax doses to 170 million.
A further $1.5 billion will be spent on other pandemic health measures, such as virus testing and hospital funding.
The Budget’s economic forecasts assume a vaccine is likely to be available to all Australians by the end of the year. But the level of international arrivals will “continue to be constrained by State and Territory quarantine caps” for the rest of this year, while international travel will be low until mid-2022.
Treasurer Josh Frydenberg said the first priority was to keep Australians safe from COVID.
“Australians have already received over 2.5 million doses,” he said on Tuesday night.